Hanoch Rappaport
Corporate Officer/Principal at The Hebrew University of Jerusalem
Profile
Hanoch Rappaport is currently the Chief Financial Officer-Employees Provident Fund at The Hebrew University of Jerusalem.
Previously, he worked as a Director at Anchiano Therapeutics Ltd.
and BioCancell Therapeutics, Inc. from 2006 to 2013.
He also worked as a Corporate Credit Officer at Bank Hapoalim BM and an Investment Manager at A.
Heifetz & Co. Mr. Rappaport holds an MBA from Tel-Aviv University and The Hebrew University of Jerusalem, and an undergraduate degree from Bar-Ilan University.
Hanoch Rappaport active positions
| Companies | Position | Start |
|---|---|---|
| The Hebrew University of Jerusalem | Corporate Officer/Principal | - |
Former positions of Hanoch Rappaport
| Companies | Position | End |
|---|---|---|
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Director/Board Member | 2013-10-31 |
| ANCHIANO THERAPEUTICS LTD. | Director/Board Member | - |
| A. Heifetz & Co. | Chief Investment Officer | - |
| BANK HAPOALIM B.M. | Corporate Officer/Principal | - |
Training of Hanoch Rappaport
| Tel-Aviv University | Masters Business Admin |
| The Hebrew University of Jerusalem | Masters Business Admin |
| Bar-Ilan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BANK HAPOALIM B.M. | Finance |
| Private companies | 3 |
|---|---|
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
| A. Heifetz & Co. |
- Stock Market
- Insiders
- Hanoch Rappaport
